IndiaInfoline » Markets » GLAXO

Glaxosmithkline Pharmaceuticals Ltd - Share Price

GLAXO

Open

1,475.00

Prev. Close

1,465.55

Turnover (lac.)

1,121

Day's High

1,495.00

Day's Low

1,465.00

52 Week's High

1,807.50

52 Week's Low

1,206.00

Book Value

129

Face Value

10

Mkt Cap (Cr.)

24,906

P/E

49.17

EPS

29.89

Divi. Yield

2.72

Glaxosmithkline Pharmaceuticals LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Glaxosmithkline Pharmaceuticals LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd646.0552.23155,009.04555.550.623,366.01106.10
Divis Laboratories Ltd3,821.8554.62101,507.22461.240.421,656.48313.47
Dr Reddys Laboratories Ltd4,893.2534.2281,371.29443.700.513,397.50979.36
Cipla Ltd938.0528.4675,702.71698.930.433,689.88233.60
Aurobindo Pharma Ltd953.0018.7355,839.95740.510.313,701.14246.88

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Glaxosmithkline Pharmaceuticals LtdSummary & Reports

GlaxoSmithKline Pharmaceuticals Ltd is one of the leading pharmaceutical companies in the India. It is a subsidiary of GlaxoSmithKline plc, UK, one of the worlds leading research-based pharmaceutical and healthcare companies. The companys product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynaecology, diabetes, oncology, card... More

Registered Office

GSK House,Dr Annie Besant Road Worli,Mumbai, Maharashtra,400030

Tell. : +91-022-24959595
Website : http://www.gsk-india.com
Email : askus@gsk.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

Reports by glaxosmithkline-pharmaceuticals-ltd-share-price

Latest Release by glaxosmithkline-pharmaceuticals-ltd-share-price

View

- <

Reco. Price

Mar 31,2021 03:35 PM

Target Price

Target Returns:

0.00%

Result Express

Glaxosmithkline Pharma Ltd's Q1FY19 standalone net profit rises 602.98% yoy to Rs96.87cr : Beats Estimates

Apr 17, 2021 08:17 PM

The company’s standalone revenue stood at Rs735.65cr, up 21.1% yoy but down 1.73% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    05 Feb 2021

    Annc. Date

    28 Dec 2020

    We wish to inform you that the in terms of the provisions of SEBI (Prohibition of Insider Trading) R... More

  • Purpose

    Board Meeting

    Exp. Date

    07 Jan 2021

    Annc. Date

    07 Jan 2021

    Pursuant to Regulation 30 and Schedule Ill (A) (7) of the Listing and Disclosure Requirements Regula... More